GlassScriptPhysician profile
Paul W Morrison
NPI 1689628422
$38,205.32
in general payments reported to CMS, 2019-2025
27 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $4,968 · 2021: $4,884 · 2022: $5,358 · 2023: $4,174 · 2024: $204 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,805 · Food and Beverage: $781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,805.40 |
| Food and Beverage | $781.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $21,826.98 | 2019-2024 | |
| Organon LLC | $8,092.14 | 2021-2024 | Nexplanon |
| Merck Sharp & Dohme LLC | $5,678.59 | 2019-2020 | |
| Olympus Corporation of The Americas | $1,215.06 | 2019-2020 | |
| Minerva Surgical, INC | $219.11 | 2019 | |
| Biogen, INC. | $202.94 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $153.91 | 2020-2022 | |
| Ethicon US, LLC | $127.99 | 2019-2023 | Monocryl |
| Astellas Pharma US INC | $92.22 | 2023-2025 | Veozah |
| Shield Therapeutics INC | $85.57 | 2022-2024 | Accrufer |
| Hologic Sales and Service, LLC | $68.90 | 2021-2023 | Coolseal Generator, Novasure, Acessa Provu System |
| Evofem Biosciences, INC. | $50.11 | 2021 | |
| Sumitomo Pharma America, INC. | $50.02 | 2023-2025 | Myfembree |
| Pfizer INC. | $43.10 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.18 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $31.76 | 2021-2022 | |
| Exeltis, USA INC. | $30.95 | 2023 | Slynd |
| Ferring Pharmaceuticals INC. | $30.39 | 2019 | |
| Applied Medical Resources Corporation | $27.01 | 2024 | |
| Amgen INC. | $25.63 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $20.37 | 2023 | |
| Sage Therapeutics, LLC | $19.53 | 2023 | |
| Axsome Therapeutics, INC. | $19.13 | 2023 | Auvelity |
| Kowa Pharmaceuticals America, INC. | $15.25 | 2023 | Seglentis |
| Avion Pharmaceuticals | $13.53 | 2021 | |
| Amag Pharmaceuticals, INC. | $12.55 | 2020 | |
| Dysis Medical, INC. | $12.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.